GILEAD SCIENCES INC Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for June 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 5,000 | 71,688 | 81,000 | |
| Jun 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 81.82 | 5,000 | 409,123 | 42,405 | 47.4 K to 42.4 K (-10.55 %) |
| Jun 25 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 5,000 | 71,688 | 47,405 | 42.4 K to 47.4 K (+11.79 %) |
| Jun 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 90,000 | 1,475,550 | 160,000 | |
| Jun 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 80.90 | 90,000 | 7,280,784 | 119,302 | 209.3 K to 119.3 K (-43.00 %) |
| Jun 18 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 90,000 | 1,475,550 | 209,302 | 119.3 K to 209.3 K (+75.44 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 16,728 | 451,489 | 57,720 | |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 80.89 | 2,000 | 161,772 | 30,705 | 32.7 K to 30.7 K (-6.12 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 80.04 | 2,020 | 161,690 | 32,705 | 34.7 K to 32.7 K (-5.82 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.10 | 12,708 | 1,005,182 | 34,725 | 47.4 K to 34.7 K (-26.79 %) |
| Jun 11 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 16,728 | 451,489 | 47,433 | 30.7 K to 47.4 K (+54.48 %) |
| Jun 05 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 82.52 | 6,426 | 530,274 | 57,174 | 63.6 K to 57.2 K (-10.10 %) |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.60 | 31,000 | 731,600 | 34,367 | |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 81.35 | 33,000 | 2,684,514 | 128,694 | 161.7 K to 128.7 K (-20.41 %) |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.60 | 31,000 | 731,600 | 161,694 | 130.7 K to 161.7 K (+23.72 %) |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 45,000 | |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 80.95 | 5,000 | 404,750 | 15,641 | 20.6 K to 15.6 K (-24.22 %) |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 843,758 | |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.32 | 140,625 | 11,435,836 | 4,429,387 | 4.6 M to 4.4 M (-3.08 %) |
| Jun 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |